BIO-TECHNE CORPORATION Business Segments Bio-Techne Corporation
Equities
TECH
US09073M1045
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 77.05 USD | +0.18% |
|
+1.61% | +6.97% |
Sales 2024 by Business Segment
Sales 2024 by Geography
Historical Breakdown of Revenue by Business Segments
Operating Income: Breakdown by Business Segment
| Fiscal Period: June | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Life Sciences Tools and Services | ||||||||||
Protein Sciences | 555M | 705M | 832M | 846M | 831M | |||||
Operating Income | 235M | 329M | 378M | 374M | 355M | |||||
Protein Platforms | - | - | - | - | - | |||||
Total Assets | - | - | - | - | - | |||||
CAPEX | - | - | - | - | - | |||||
D&A | - | - | - | - | - | |||||
Operating Income | - | - | - | - | - | |||||
Medical Testing, Analyzing, and Diagnostic Equipment | ||||||||||
Diagnostics and Genomics | 185M | 228M | 275M | 293M | 326M | |||||
Operating Income | 14.96M | 38.42M | 48.98M | 43.04M | 24.55M | |||||
Diagnostics | - | - | - | - | - | |||||
Total Assets | - | - | - | - | - | |||||
CAPEX | - | - | - | - | - | |||||
D&A | - | - | - | - | - | |||||
Operating Income | - | - | - | - | - | |||||
Other Revenue | - | - | - | - | 4.15M | |||||
Total Assets | - | - | - | - | - | |||||
D&A | - | - | - | - | - | |||||
Operating Income | - | - | - | - | - | |||||
Intersegment Revenue | -1.21M | -1.28M | -1.56M | -1.65M | -2.39M | |||||
Operating Income | -34.26M | -51.85M | -46.4M | -41.22M | -40.28M | |||||
Operating Income | -4.02M | -5.06M | -5.28M | -6.53M | -9.14M | |||||
Protein and Genome Sequence Products | ||||||||||
Biotechnology | - | - | - | - | - | |||||
Total Assets | - | - | - | - | - | |||||
CAPEX | - | - | - | - | - | |||||
D&A | - | - | - | - | - | |||||
Operating Income | - | - | - | - | - |
Geographical Revenue Distribution History
| Fiscal Period: June | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
United States | 404M | 502M | 614M | 642M | 658M | |||||
EMEA, Excluding United Kingdom | 155M | 204M | 219M | 220M | 241M | |||||
Greater China | 68.79M | 87.56M | 112M | 114M | 99.47M | |||||
Total Assets | 5.99M | 15.54M | 4.99M | 3.72M | 11.9M | |||||
APAC, Excluding Greater China | 60.36M | 69.01M | 76.14M | 73.19M | 73.9M | |||||
United Kingdom | 30.41M | 40.94M | 48.64M | 49.46M | 50.01M | |||||
Rest of World | 19.43M | 27.17M | 35.22M | 37.49M | 36.5M | |||||
Other Europe | - | - | - | - | - | |||||
Other Asia | - | - | - | - | - | |||||
Total Assets | 662M | 785M | 727M | 733M | 655M | |||||
China | - | - | - | - | - | |||||
Total Assets | - | - | - | - | - | |||||
Europe | - | - | - | - | - | |||||
Total Assets | 25.47M | 23.32M | 22.5M | 23.82M | 91M |
- Stock Market
- Equities
- TECH Stock
- Financials Bio-Techne Corporation
- Business Segments